IBO Intrinsic Valuation and Fundamental Analysis - Universal Ibogaine Inc - Alpha Spread

Watchlist Manager

Watchlist

Price: 0.005 CAD

Market Cap: CA$1.6m

Intrinsic Value

IBO doesn't have a meaningful market cap.

There is not enough data to reliably calculate the intrinsic value for Universal Ibogaine Inc.

Do our valuations actually work? See backtest results .

Fundamental Analysis

What Universal Ibogaine Does

Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The firm is transforming addiction treatment using medicalized ibogaine through a planned Canadian clinical trial focused on opioid use disorders. The firm is engaged in developing a holistic addiction treatment protocol at its Kelburn Recovery Center (located near Winnipeg, Manitoba), which, paired with the planned ibogaine detox protocol, is intended to treat addiction and improve the lives of individuals and families affected by addiction.

Headquarters: Canada CA
IPO date: Jun 21, 2017

Read the full company overview

View Company Overview

Apr 2024 Jul 2024 Oct 2024 Jan 2025 Apr 2025

Wall St Price Targets

Capital Returns

Buyback Yield

What is Buyback Yield?

Debt Paydown Yield

What is Debt Paydown Yield?

Competitive Landscape

Continue IBO Research

Relative Valuation

Wall St Estimates

Financial Statements

Join 361,900+ value investors using Alpha Spread

Create Free Account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Valuation Backtest Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.